Fig. 6: LYMTACs display multi-pharmacology.

LYMTAC is an SM-based, proximity-inducing modality that functions intracellularly to relocalize and degrade membrane proteins via the lysosome. LYMTACs inhibit POI signaling via relocalization and subsequent lysosomal degradation.